From: Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study
Gene | Polymorphism | Genotypes (N analyzed and %) | Grouping (N analyzed and %) | Total | |||
---|---|---|---|---|---|---|---|
GCLC | −129C > Ta | CC | CT | TT | CC | CT + TT | 181 (100%) |
145 (80.11%) | 29 (16.02%) | 7 (3.87%) | 145 (80.11%) | 36 (19.89%) | |||
−3506A > Gb | AA | AG | GG | AA | AG + GG | 181 (100%) | |
119 (65.75%) | 56 (30.94%) | 6 (3.31%) | 119 (65.75%) | 62 (35.25%) | |||
M1 | Deletionc | - | + | 181 (100%) | |||
73 (40.33%) | 108 (59.67%) | ||||||
T1 | Deletiond | - | + | 181 (100%) | |||
63 (34.81%) | 118 (65.19%) | ||||||
M1/T1 | Deletion | −/− | +/− and −/+ | +/+ | 181 (100%) | ||
19 (10.50%) | 99 (54.70%) | 63 (34.80%) | |||||
GSTP1 | +313A > Gf | AA | AG | GG | AA | AG + GG | 181 (100%) |
98 (54.14%) | 74 (40.88%) | 9 (4.98%) | 98 (54.14%) | 83 (45.86%) |